| |
| |
|
| Insider
Information: |
Northcott John |
| Relationship: |
SVP & Chief Commercial... |
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
231,445 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$307,649 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
231,445 |
|
|
| Total
Value |
$307,649 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -285.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
VP, Marketing, Comm St... |
2015-03-02 |
8,235 |
2015-03-02 |
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
SVP & Chief Commercial... |
2022-05-16 |
223,210 |
2019-12-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2022-05-16 |
4 |
S |
$3.95 |
$18,138 |
D/D |
(4,592) |
223,210 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2022-02-16 |
4 |
S |
$10.95 |
$53,129 |
D/D |
(4,852) |
227,802 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2021-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,800 |
232,654 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2021-11-16 |
4 |
S |
$13.16 |
$79,763 |
D/D |
(6,061) |
194,854 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2021-08-16 |
4 |
S |
$13.83 |
$85,635 |
D/D |
(6,192) |
200,915 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2021-05-17 |
4 |
S |
$18.30 |
$111,356 |
D/D |
(6,085) |
207,107 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2021-02-16 |
4 |
S |
$22.37 |
$343,558 |
D/D |
(15,358) |
213,192 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
28,550 |
228,550 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
SVP & Chief Commercial Officer |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
200,000 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Marketing, Comm Strategy |
• • – |
2015-03-02 |
4 |
D |
$0.94 |
$2,834 |
D/D |
(3,015) |
8,235 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
VP, Marketing, Comm Strategy |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
11,250 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
